We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

WERFEN

Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App




Anticoagulant Adjustment Evaluated Using Different Prothrombin Time Tests

By LabMedica International staff writers
Posted on 26 Nov 2020
Preanalytical variables may affect the results of routine coagulation assays. More...
One important variable is hematocrit (Ht), which affects coagulation testing results. A sample with high Ht has lower plasma quantity, resulting in a dilution effect on the sample by an excess of the anticoagulant sodium citrate.

The prothrombin time/international normalized ratio (PT/INR) test is the assay used to monitor dose-adjustments of vitamin K antagonist (VKA) treatment. Thus, for patients on monitored oral anticoagulant therapy who present an elevated Ht, adjustment of sodium citrate volume is essential, otherwise, these patients would have an incorrect diagnosis or treatment.

Clinical Laboratory Scientists at the Universidade de Sao Paulo (Sao Paulo, Brazil) enrolled 181 patients from the pulmonary hypertension ambulatory group with elevated Ht (>55%) and on warfarin therapy. All patients were diagnosed with polycythemia due to pulmonary hypertension and received anticoagulation treatment at the anticoagulation ambulatory center.

Paired citrate-adjusted and unadjusted blood specimens were tested using the PT test using two different thromboplastin reagents that are routinely used in their laboratory: the first was the HemosIL RecombiPlasTin 2G, with a thromboplastin (International Sensitivity Index [ISI] 1.00) of lyophilized recombinant human tissue factor (RTF), and the second reagent was HemosIL PT-Fibrinogen HS Plus with a thromboplastin (ISI 1.24) lyophilized from rabbit brain extract (HS Plus). Both reagents were produced by Instrumentation Laboratories (Bedford, MA, USA). The results are expressed as the international normalized ratio (INR). The correlation and percent change (% change) between sample pairs were calculated.

The scientists reported that the INR-RTF results from adjusted and unadjusted citrate blood specimens showed a strong correlation. The INR median was 2.25 for citrate-adjusted samples and was 2.22 for citrate-unadjusted samples. For samples with Ht >62%, the % change between sample pairs was >10%. Results using HS Plus showed a moderate correlation between citrate-adjusted and unadjusted samples. The INR median was 2.51 for citrate-adjusted samples and 3.45 for citrate-unadjusted samples. For samples with Ht>55%, the % change between sample pairs was higher than 10%.

The authors concluded that the adjustment of citrate concentration in samples with markedly elevated hematocrit depends on the PT reagent used in the routine tests, and each laboratory must perform a validation assay. Their data suggest that with RecombiPlasTin 2G reagent, samples of patients with polycythemia on warfarin therapy with Ht up to 62% could be obtained in an unadjusted citrate concentration tube. Using this PT reagent, can reduce the number of collection tubes and length of patient stay and avoid recall of patients, meaning lower treatment costs and faster patient care. The study was published in the November. 2020 issue of the journal Practical Laboratory Medicine.

Related Links:
Universidade de Sao Paulo
Instrumentation Laboratories

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Gold Member
Connectivity Solution
EKF Link
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New evidence now questions whether a single stool-test cutoff should be applied uniformly across all age groups.(Photo courtesy of Paul Maguire - Adobe Stock)

Study Questions Uniform Stool-Test Cutoff Across Age Groups

Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.